Roivant Reports Earnings Beat Despite Revenue Miss

Roivant Sciences (NASDAQ:ROIV) reported fourth-quarter adjusted earnings per share of $0.28, exceeding expectations for a loss, which led to an 9.89% rise in pre-market trading despite revenue falling short of forecasts.

By Fiona Craig Wed, May 20, 2026 at 3:45 PM GMT+3 2 min read · Yahoo Finance · May 20, 2026, 12:45 UTC

Roivant Reports Earnings Beat Despite Revenue Miss

Tickers: $MRNA $ROIV

Topics: clinical_trials litigation_settlement pharmaceuticals

Read the full article at Yahoo Finance

More World news

SchoolWise Partners Advises on Sale of Wyalusing Valley and Wysox Children's Centers PR Newswire · November 12, 2026, 15:57 UTC
Jensen Huang Resigns as Nvidia CEO Amid Personal Scandal and Leadership Crisis CNBC · November 12, 2026, 15:45 UTC
Keurig Dr Pepper Launches $2 Billion Equity Offering to Reduce Debt Ahead of Corporate Split Seeking Alpha · November 12, 2026, 15:51 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC
Oman Investment Authority Signs Multi-Billion Dollar Investment Package with Chinese Partners PR Newswire · November 12, 2026, 15:52 UTC
Nvidia Shares Drop 35% Following Resignation of CEO Jensen Huang Motley Fool · November 12, 2026, 15:49 UTC
Pomerantz Law Firm Investigates Potential Securities Fraud at ClearPoint Neuro (CLPT) PR Newswire · November 12, 2026, 15:50 UTC
Nvidia CEO Jensen Huang Resigns Amid Board Investigation The Verge · November 12, 2026, 15:48 UTC
GFL Environmental Shares Decline Following Preferred Share Conversion and Block Trade Seeking Alpha · November 12, 2026, 15:48 UTC